CAPSTONE INVESTMENT ADVISORS, LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 63 filers reported holding CTI BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q3 2021$149,000
+67.4%
50,445
+81.7%
0.00%–
Q4 2020$89,000–27,770–0.00%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders